Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa

Updated on: April 09,2024 18

Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa

Updated on:April 09,2024 18

Country-specific norms created for cancer-related quality of life

(HealthDay)—Country-specific norms have been established for the European Organisation for Research and Treatment of Cancer (EORTC) questionnaire to measure the self-reported quality of life of cancer

Updated on: April 14,2024 17

Country-specific norms created for cancer-related quality of life

(HealthDay)—Country-specific norms have been established for the European Organisation for Research and Treatment of Cancer (EORTC) questionnaire to measure the self-reported quality of life of cancer

Updated on:April 14,2024 17

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Updated on: April 14,2024 20

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Updated on:April 14,2024 20

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024 10

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024 10

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre

Updated on: May 13,2024 5

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre

Updated on:May 13,2024 5

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki

Updated on: January 02,2024 9

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki

Updated on:January 02,2024 9

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024 8

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024 8

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on: February 18,2024 11

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on:February 18,2024 11

Research identifies new target that may prevent blood cancer

by Bill Snyder,Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainAn international coalition of biomedical researchers co-led by Alexander Bick, MD, Ph.D., at Vanderbilt Unive

Updated on: February 18,2024 14

Research identifies new target that may prevent blood cancer

by Bill Snyder,Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainAn international coalition of biomedical researchers co-led by Alexander Bick, MD, Ph.D., at Vanderbilt Unive

Updated on:February 18,2024 14

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-

Updated on: September 28,2024 0

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-

Updated on:September 28,2024 0

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on: May 09,2024 8

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on:May 09,2024 8

New treatment could be advance against cervical precancers

by Ernie MundellWomen who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected.These cells—called cervical intraepithelial neoplasias

Updated on: April 28,2024 0

New treatment could be advance against cervical precancers

by Ernie MundellWomen who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected.These cells—called cervical intraepithelial neoplasias

Updated on:April 28,2024 0